Navigation Links
India Fast Become Prime Location for Clinical Trials, but Vigilance Called for

India is fast becoming a prime location for clinical trials for many pharmaceutical giants//, observers say.

Pfizer, BristolMyers Squibb, GlaxoSmithkline, Eli Lilly are among those big firms that conduct the trials in the country.

Currently over 226 clinical trials approved by the U.S. Food and Drug Administration (FDA) are in India.

Faced with the increasing costs of clinical trials and a shortage of willing participants at home, western drug companies are looking at off-shoring the trials to the third world.

India has perhaps the world's largest patient pool, it is pointed out. Moreover, it may be easy to pick out those who may not be taking any other medicine.

But the main consideration is costs — industry watchers say drug companies may save up to 50% of the costs of new drug development by conducting trials in India.

Big cities are favorite spots for these trials, with Delhi having 76 trials, Mumbai 86, Chennai 50 and Bangalore 64, it is reported.

Many clinical research organizations (CROs) have sprouted up, offering to carry out such trials. They are getting business worth up to 120 million US dollars a year. It is expected that clinical trials estimated to cost two billion dollars could end up in India by 2010.

The Center has made changes in laws and regulations to accommodate the clinical trial boom.

Apart from changes in patent laws, which will protect data confidentiality, initial or phase-1 trials are also permitted.

A Framework for Good Clinical Practices has also been announced. In the budget for 2007-08, the service tax on clinical trials was done away with.

However, many doubt whether India's top regulatory body, the Drug Controller General of India, is technically equipped to cope with the influx.

In recent years, there has been a spate of failures of clinical trials with many of the top pharma compani es being forced to withdraw drugs after adverse reports. While Bristol-Myers Squibb terminated a new diabetes drug, Astra Zeneca halted work on a new drug for stroke patients. And Pfizer did so with its cholesterol-reducing Torcetrapib.

They all pull out only on realizing irreversible damage has been caused to the subjects. But no one will compensate them or their families.

Necessary measures to protect the health of the Indian citizens should be put in place first, urge activists. That is far more important than earning dollars, they stress.
'"/>




Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)... LAKES, N.J. , Sept. 12, 2017  Consumer reviews on ... Embrace Hearing as the number one company for hearing aids, ... ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides ...
Breaking Medicine Technology: